Neuroferritinopathy

Parkinsonism and Related Disorders

Volumn 18, Issue 8, 2012, Pages 909-915

  Lehn, Alexander ^a   Boyle, Richard ^a   Brown, Helen ^a   Airey, Caroline ^a   Mellick, George ^a,b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

Basal ganglia; Dystonia; Iron deposition; Neuroferritinopathy; Parkinsonism

Indexed keywords

AMANTADINE; AMITRIPTYLINE; APOMORPHINE; BACLOFEN; BOTULINUM TOXIN; CARBAMAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; DANTROLENE; DEANOL; DEFERIPRONE; DEFEROXAMINE; DIAZEPAM; DOPAMINE RECEPTOR BLOCKING AGENT; FERRITIN; GABAPENTIN; HALOPERIDOL; IRON; LEVODOPA; LORAZEPAM; MIRTAZAPINE; OLANZAPINE; PAROXETINE; RISPERIDONE; SULPIRIDE; TETRABENAZINE; TIAPRIDE; TRIHEXYPHENIDYL; UNINDEXED DRUG; VALPROIC ACID;

AUTOSOMAL DOMINANT DISORDER; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; DEGENERATIVE DISEASE; DEPRESSION; DYSARTHRIA; DYSPHAGIA; FAMILIAL DISEASE; FERRITIN BLOOD LEVEL; FOCAL DYSTONIA; GENE MUTATION; HUMAN; IRON CHELATION; IRON RESTRICTION; MOTOR DYSFUNCTION; NEUROFERRITINOPATHY; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PARKINSONISM; PHLEBOTOMY; PRIORITY JOURNAL; REVIEW; SEDATION; SIDE EFFECT;

APOFERRITINS; BRAIN; HUMANS; IRON; IRON METABOLISM DISORDERS; MALE; MIDDLE AGED; MUTATION; NEUROAXONAL DYSTROPHIES; NEURONS; PEDIGREE;

EID: 84865598758     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2012.06.021     Document Type: Review

References (35)

1. McNeill A., Chinnery P.F. Neurodegeneration with brain iron accumulation. Handb Clin Neurol 2011, 100:161-172.
2. Keogh M.J., Khan A., Gorman G., McNeill A., Horvath R., Burn J., et al. An unusual gait following the discovery of a new disease. Pract Neurol 2011 Apr., 11(2):81-84.
3. Zecca L., Youdim M.B.H., Riederer P., Connor J.R., Crichton R.R. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 2004 Nov., 5(11):863-873.
4. Friedman A., Arosio P., Finazzi D., Koziorowski D., Galazka-Friedman J. Ferritin as an important player in neurodegeneration. Parkinsonism Relat Disord 2011 Jul., 17(6):423-430.
5. Arosio P., Ingrassia R., Cavadini P. Ferritins: a family of molecules for iron storage, antioxidation and more. Biochim Biophys Acta 2009 Jul., 1790(7):589-599.
6. Zhao G., Bou-Abdallah F., Arosio P., Levi S., Janus-Chandler C., Chasteen N.D. Multiple pathways for mineral core formation in mammalian apoferritin. The role of hydrogen peroxide. Biochemistry 2003 Mar. 18, 42(10):3142-3150.
7. Santambrogio P., Levi S., Cozzi A., Rovida E., Albertini A., Arosio P. Production and characterization of recombinant heteropolymers of human ferritin H and L chains. J Biol Chem 1993 Jun. 15, 268(17):12744-12748.
8. Harrison P.M., Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1996 Jul. 31, 1275(3):161-203.
9. Pham C.G., Bubici C., Zazzeroni F., Papa S., Jones J., Alvarez K., et al. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 2004 Nov. 12, 119(4):529-542.
10. Baldi A., Lombardi D., Russo P., Palescandolo E., De Luca A., Santini D., et al. Ferritin contributes to melanoma progression by modulating cell growth and sensitivity to oxidative stress. Clin Cancer Res 2005 May 1, 11(9):3175-3183.
11. Galazka-Friedman J., Bauminger E.R., Szlachta K., Friedman A. The role of iron in neurodegeneration-Mössbauer spectroscopy, electron microscopy, enzyme-linked immunosorbent assay and neuroimaging studies. J Phys Condens Matter 2012 Jun. 20, 24(24):244106.
12. Levi S., Arosio P. Mitochondrial ferritin. Int J Biochem Cell Biol 2004 Oct., 36(10):1887-1889.
13. Curtis A.R., Fey C., Morris C.M., Bindoff L.A., Ince P.G., Chinnery P.F., et al. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 2001 Aug., 28(4):350-354.
14. Maciel P., Cruz V.T., Constante M., Iniesta I., Costa M.C., Gallati S., et al. Neuroferritinopathy: missense mutation in FTL causing early-onset bilateral pallidal involvement. Neurology 2005 Aug. 23, 65(4):603-605.
15. Levi S., Cozzi A., Arosio P. Neuroferritinopathy: a neurodegenerative disorder associated with L-ferritin mutation. Best Pract Res Clin Haematol 2005 Jun. 1, 18(2):265-276.
16. Vidal R., Ghetti B., Takao M., Brefel-Courbon C., Uro-Coste E., Glazier B.S., et al. Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene. J Neuropathol Exp Neurol 2004 Apr. 1, 63(4):363-380.
17. Mancuso M., Davidzon G., Kurlan R.M., Tawil R., Bonilla E., Di Mauro S., et al. Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights. J Neuropathol Exp Neurol 2005 Apr. 1, 64(4):280-294.
18. Vidal R., Miravalle L., Gao X., Barbeito A.G., Baraibar M.A., Hekmatyar S.K., et al. Expression of a mutant form of the ferritin light chain gene induces neurodegeneration and iron overload in transgenic mice. J Neurosci 2008 Jan. 2, 28(1):60-67.
19. Cozzi A., Rovelli E., Frizzale G., Campanella A., Amendola M., Arosio P., et al. Oxidative stress and cell death in cells expressing L-ferritin variants causing neuroferritinopathy. Neurobiol Dis 2010 Jan., 37(1):77-85.
20. Barbeito A.G., Garringer H.J., Baraibar M.A., Gao X., Arredondo M., Núñez M.T., et al. Abnormal iron metabolism and oxidative stress in mice expressing a mutant form of the ferritin light polypeptide gene. J Neurochem 2009 May, 109(4):1067-1078.
21. Ory-Magne F., Brefel-Courbon C., Payoux P., Debruxelles S., Sibon I., Goizet C., et al. Clinical phenotype and neuroimaging findings in a French family with hereditary ferritinopathy (FTL498-499InsTC). Mov Disord 2009 Aug. 15, 24(11):1676-1683.
22. Ohta E., Takiyama Y. MRI findings in neuroferritinopathy. Neurol Res Int 2012, 2012:197438.
23. Baraibar M.A., Barbeito A.G., Muhoberac B.B., Vidal R. Iron-mediated aggregation and a localized structural change characterize ferritin from a mutant light chain polypeptide that causes neurodegeneration. J Biol Chem 2008 Nov. 14, 283(46):31679-31689.
24. Deng X., Vidal R., Englander E.W. Accumulation of oxidative DNA damage in brain mitochondria in mouse model of hereditary ferritinopathy. Neurosci Lett 2010 Jul. 19, 479(1):44-48.
25. Chinnery P.F., Crompton D.E., Birchall D., Jackson M.J., Coulthard A., Lombès A., et al. Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation. Brain 2007 Jan., 130(Pt 1):110-119.
26. Ondo W.G., Adam O.R., Jankovic J., Chinnery P.F. Dramatic response of facial stereotype/tic to tetrabenazine in the first reported cases of neuroferritinopathy in the United States. Mov Disord 2010 Oct. 30, 25(14):2470-2472.
27. Wills A.J., Sawle G.V., Guilbert P.R., Curtis A.R.J. Palatal tremor and cognitive decline in neuroferritinopathy. J Neurol Neurosurg Psychiatr 2002 Jul., 73(1):91-92.
28. Mir P., Edwards M.J., Curtis A.R.J., Bhatia K.P., Quinn N.P. Adult-onset generalized dystonia due to a mutation in the neuroferritinopathy gene. Mov Disord 2005 Feb., 20(2):243-245.
29. Crompton D.E., Chinnery P.F., Bates D., Walls T.J., Jackson M.J., Curtis A.J., et al. Spectrum of movement disorders in neuroferritinopathy. Mov Disord 2005 Jan., 20(1):95-99.
30. Ohta E., Nagasaka T., Shindo K., Toma S., Nagasaka K., Ohta K., et al. Neuroferritinopathy in a Japanese family with a duplication in the ferritin light chain gene. Neurology 2008 Apr. 15, 70(16 Pt 2):1493-1494.
31. Kubota A., Hida A., Ichikawa Y., Momose Y., Goto J., Igeta Y., et al. A novel ferritin light chain gene mutation in a Japanese family with neuroferritinopathy: description of clinical features and implications for genotype-phenotype correlations. Mov Disord 2009 Feb. 15, 24(3):441-445.
32. Devos D., Tchofo P.J., Vuillaume I., Destée A., Batey S., Burn J., et al. Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation. Brain 2009 Jun., 132(Pt 6). e109.
33. Wills A. Hereditary neuroferritinopathy presenting with palatal tremor, orofacial dyskinesias, bulbar symptoms, and unsteadiness of gait. Move Disord 2003.
34. Mittal S., Wu Z., Neelavalli J., Haacke E.M. Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. Am J of Neuroradiology 2009 Feb., 30(2):232-252.
35. Kruer M.C., Boddaert N., Schneider S.A., Houlden H., Bhatia K.P., Gregory A., et al. Neuroimaging features of neurodegeneration with brain iron accumulation. Am J of Neuroradiology 2012 Mar., 33(3):407-414.